Chemical entities to be used for Wee1 inhibition for the treatment of cancer
The present invention relates to compounds of formula (I) or pharmaceutical acceptable salts, wherein R1, R2, R3, A, B, and n are defined in the description. The present invention relates also to compositions containing compounds of formula (I) which are useful for inhibiting kinases such as wee-1 a...
Saved in:
Main Authors | , , , |
---|---|
Format | Patent |
Language | English |
Published |
06.05.2014
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention relates to compounds of formula (I) or pharmaceutical acceptable salts, wherein R1, R2, R3, A, B, and n are defined in the description. The present invention relates also to compositions containing compounds of formula (I) which are useful for inhibiting kinases such as wee-1 and methods of treating diseases such as cancer. |
---|---|
Bibliography: | Application Number: US201213547314 |